The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 14, 2014
Filed:
Sep. 29, 2010
Applicant:
Kirk W. Johnson, Moraga, CA (US);
Inventor:
Kirk W. Johnson, Moraga, CA (US);
Assignees:
Baxter Healthcare S.A., Glattpark (Opfikon), CH;
Baxter International Inc., Deerfield, IL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/727 (2006.01); A01N 43/04 (2006.01); A61K 31/715 (2006.01); A61K 31/70 (2006.01); A61K 38/37 (2006.01); C07K 14/755 (2006.01); A61K 38/43 (2006.01); A61K 38/57 (2006.01); C07K 14/745 (2006.01); A61K 38/48 (2006.01); A61K 31/737 (2006.01); A61K 31/731 (2006.01); A61K 38/36 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/727 (2013.01); A61K 38/4846 (2013.01); Y10S 514/834 (2013.01); A61K 31/737 (2013.01); A61K 31/731 (2013.01); A61K 38/36 (2013.01); A61K 45/06 (2013.01); A61K 38/37 (2013.01);
Abstract
Methods for treating bleeding disorders using non-anticoagulant sulfated polysaccharides (NASPs) as procoagulants are disclosed. NASPs can be administered as single agents, or in combination with one another, or with other medications (such as factors VII, VIII and IX) to promote hemostasis. In particular, the use of NASPs in treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions is described.